Medical Science Liaison - Gyn Oncology (West Coast)
Natera- Full Time
- Junior (1 to 2 years)
Employment Type: Full time Salary: $135,000 - $190,000 (California range; may vary by location) Location Type: Field-based
Tempus is seeking a high-performing and experienced Medical Science Liaison (MSL) specializing in Neuropsychiatry. This role is crucial for supporting the commercial, research, and educational objectives of the company. The ideal candidate will be a field-based MSL with a strong clinical and scientific background in psychiatry genomic testing and excellent communication skills. This position requires approximately 50% travel.
Tempus is passionate about precision medicine and advancing the healthcare industry. Our proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical, and other benefits depending on the position.
Note: The expected salary range is applicable if the role is performed from California and may vary for other locations. Actual salary may vary based on qualifications and experience. For remote roles open to individuals in unincorporated Los Angeles, Tempus reasonably believes that criminal history may have a direct, adverse, and negative relationship with specific job duties.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.